Velocity is the world's leading integrated site organization.
Sponsors and CROs trust Velocity to deliver high-quality clinical trial data and patient care with unprecedented efficiency.
Simplify everything from site selection to study close-out
Velocity unifies operational processes to provide world-class sites, reliable enrollment, and predictably high performance for your trials.
News
Dr. Rosenstock is the Lead Investigator for Lilly’s ACHIEVE-1 Trial for Oral GLP-1, Orforglipron, Results Published in NEJM
Tremendous results! Julio Rosenstock, MD, recently authored and presented results for Lilly’s Phase 3 ACHIEVE-1 trial. The once-daily pill significantly reduced A1C (1.3-1.6%) and led to an average 16-pound weight … Read more
Velocity Joins Advarra’s Council for Responsible Use of AI in Clinical Trials as Founding Member
We’re proud to share that Velocity Clinical Research has joined Advarra’s newly launched Council for Responsible Use of AI in Clinical Trials as a founding member—alongside fellow industry leaders from … Read more
BioSpace Article: U.S. Uncertainty Creates Clinical Trial Leadership Opportunity for Europe
The U.S. clinical research landscape faces uncertainty. NIH grant cancellations, FDA staffing cuts, and regulatory uncertainty are creating real challenges for the industry’s traditional leader. Europe has an opportunity if … Read more
Launching the 2025 U.S. Clinical Trials Patient Survey
At Velocity Clinical Research, we’re proud to be one of the largest clinical trial patient networks in the world, with access to over one million patients in our database across … Read more